HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE
Breast cancer is a heterogenous disease, showing as several different clinical and histologic types. Most of breast cancers express hormone receptors for estrogen and progesterone, which are considered as estrogen receptor-positive and progesterone-receptor-positive, respectively. Endocrine thera...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bulgarian Association of Young Surgeons
2016-08-01
|
Series: | International Journal of Surgery and Medicine |
Online Access: | http://dx.doi.org/10.5455/ijsm.pi3kinhibitorbreastcancer |